title: Isocyanides inhibit human heme oxygenases at the verdoheme stage.
abstract: Heme oxygenases (HO) catalyze the oxidative cleavage of heme to generate biliverdin, CO, and free iron. In humans, heme oxygenase-1 (hHO-1) is overexpressed in tumor tissues, where it helps to protect cancer cells from anticancer agents, while HOs in fungal pathogens, such as Candida albicans, function as the primary means of iron acquisition. Thus, HO can be considered a potential therapeutic target for certain diseases. In this study, we have examined the equilibrium binding of three isocyanides, isopropyl, n-butyl, and benzyl, to the two major human HO isoforms (hHO-1 and hHO-2), Candida albicans HO (CaHmx1), and human cytochrome P450 CYP3A4 using electronic absorption spectroscopy. Isocyanides coordinate to both ferric and ferrous HO-bound heme, with tighter binding by the more hydrophobic isocyanides and 200-300-fold tighter binding to the ferrous form. Benzyl isocyanide was the strongest ligand to ferrous heme in all the enzymes. Because the dissociation constants (KD) of the ligands for ferrous heme-hHO-1 were below the limit of accuracy for equilibrium titrations, stopped-flow kinetic experiments were used to measure the binding parameters of the isocyanides to ferrous hHO-1. Steady-state activity assays showed that benzyl isocyanide was the most potent uncompetitive inhibitor with respect to heme with a KI = 0.15 microM for hHO-1. Importantly, single turnover assays revealed that the reaction was completely stopped by coordination of the isocyanide to the verdoheme intermediate rather than to the ferric heme complex. Much tighter binding of the inhibitor to the verdoheme intermediate differentiates it from inhibition of, for example, CYP3A4 and offers a possible route to more selective inhibitor design.
authors.affiliation: Department of Pharmaceutical Chemistry, University of California, 600 16th Street, San Francisco, California 94158-2517, USA.
authors.forename: John P
authors.initials: JP
authors.lastname: Evans
authors.forename: Sylvie
authors.initials: S
authors.lastname: Kandel
authors.forename: Paul R
authors.initials: PR
authors.lastname: Ortiz de Montellano
mesh_terms: D000097:Acetonitriles / Q000737:chemistry* / Q000378:metabolism; D000818:Animals; D001665:Binding Sites; D003486:Cyanides / Q000737:chemistry* / Q000378:metabolism; D005290:Ferric Compounds / Q000378:metabolism; D005296:Ferrous Compounds / Q000378:metabolism; D006418:Heme / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism; D006419:Heme Oxygenase (Decyclizing) / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D051547:Heme Oxygenase-1 / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D009570:Nitriles / Q000737:chemistry* / Q000378:metabolism; D051381:Rats
chemical_list: D000097:Acetonitriles; D003486:Cyanides; D005290:Ferric Compounds; D005296:Ferrous Compounds; D009570:Nitriles; C099547:verdoheme; C006725:benzyl cyanide; C002990:butyl isocyanide; D006418:Heme; C039089:isopropyl isocyanide; D006419:Heme Oxygenase (Decyclizing); D051547:Heme Oxygenase-1; C105245:heme oxygenase-2
references.citation: Circulation. 2006 Nov 14;114(20):2178-89
references.pmid: 17101869
references.citation: J Biol Chem. 2003 Mar 7;278(10):7834-43
references.pmid: 12500973
references.citation: Crit Rev Toxicol. 1992;22(1):1-21
references.pmid: 1616599
references.citation: Arch Biochem Biophys. 1993 Aug 15;305(1):123-31
references.pmid: 8342945
references.citation: J Biol Chem. 1990 Feb 25;265(6):3168-76
references.pmid: 2303446
references.citation: J Med Chem. 2007 Aug 9;50(16):3804-13
references.pmid: 17629261
references.citation: Br J Pharmacol. 2006 Feb;147(3):307-15
references.pmid: 16331285
references.citation: Eur J Pharmacol. 1994 May 17;267(3):263-7
references.pmid: 7522180
references.citation: Microbiology (Reading). 2003 Mar;149(Pt 3):579-588
references.pmid: 12634327
references.citation: J Biol Chem. 1978 Jun 25;253(12):4224-9
references.pmid: 96115
references.citation: J Biol Chem. 2007 Dec 7;282(49):35741-8
references.pmid: 17916555
references.citation: Biochemistry. 1996 Jan 23;35(3):930-6
references.pmid: 8547275
references.citation: J Biol Chem. 2000 Feb 25;275(8):5297-307
references.pmid: 10681502
references.citation: J Biol Chem. 2007 Dec 28;282(52):37624-31
references.pmid: 17965015
references.citation: Mol Pharmacol. 1993 Jun;43(6):965-9
references.pmid: 8391121
references.citation: J Med Chem. 2001 Mar 15;44(6):873-85
references.pmid: 11300869
references.citation: Biochemistry. 1998 Feb 17;37(7):1839-47
references.pmid: 9485309
references.citation: Methods Enzymol. 1978;52:342-50
references.pmid: 672638
references.citation: Science. 2004 Jul 30;305(5684):683-6
references.pmid: 15256616
references.citation: Biochemistry. 2007 Feb 20;46(7):1860-7
references.pmid: 17253780
references.citation: J Med Chem. 2008 Oct 9;51(19):5943-52
references.pmid: 18798608
references.citation: J Biol Chem. 2001 Apr 6;276(14):10612-9
references.pmid: 11121422
references.citation: Pediatr Res. 1992 Feb;31(2):196-201
references.pmid: 1542552
references.citation: Trends Pharmacol Sci. 1997 Jun;18(6):193-5
references.pmid: 9226997
references.citation: Science. 2004 Sep 10;305(5690):1626-8
references.pmid: 15361626
references.citation: J Biol Chem. 1993 Oct 25;268(30):22357-62
references.pmid: 8226746
references.citation: Bioconjug Chem. 2002 Sep-Oct;13(5):1031-8
references.pmid: 12236785
references.citation: Can J Physiol Pharmacol. 1996 Mar;74(3):278-85
references.pmid: 8773407
references.citation: J Biol Chem. 1980 May 10;255(9):4144-30
references.pmid: 7372671
references.citation: J Biol Chem. 1983 Dec 10;258(23):14219-32
references.pmid: 6643477
references.citation: Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14848-53
references.pmid: 9405702
references.citation: Gen Pharmacol. 1985;16(3):193-7
references.pmid: 4018535
references.citation: Biochemistry. 1995 Apr 4;34(13):4421-7
references.pmid: 7703255
references.citation: Biochim Biophys Acta. 1997 Jan 4;1337(1):66-74
references.pmid: 9003438
references.citation: J Mol Biol. 2004 Jul 30;341(1):7-13
references.pmid: 15312758
references.citation: J Biol Chem. 1994 Jan 14;269(2):1010-4
references.pmid: 8288555
references.citation: Apoptosis. 2004 Jan;9(1):27-35
references.pmid: 14739596
references.citation: Proc Natl Acad Sci U S A. 1981 Oct;78(10):6466-70
references.pmid: 6947237
references.citation: Biochemistry. 2006 Dec 12;45(49):14772-80
references.pmid: 17144670
references.citation: J Biol Chem. 2004 Sep 10;279(37):38091-4
references.pmid: 15258162
references.citation: J Biol Chem. 1986 Aug 5;261(22):10228-39
references.pmid: 3733708
references.citation: J Biol Chem. 1997 Mar 14;272(11):6909-17
references.pmid: 9054378
references.citation: J Biol Chem. 2005 Nov 4;280(44):36833-40
references.pmid: 16115896
references.citation: Bioorg Med Chem. 2007 May 1;15(9):3225-34
references.pmid: 17339115
references.citation: Physiol Rev. 2006 Apr;86(2):583-650
references.pmid: 16601269
references.citation: Bioorg Med Chem Lett. 2005 Mar 1;15(5):1457-61
references.pmid: 15713406
references.citation: Mol Pharmacol. 1988 May;33(5):500-8
references.pmid: 3285175
references.citation: Biochim Biophys Acta. 1997 Jun 6;1335(3):253-64
references.pmid: 9202188
references.citation: J Biol Chem. 1998 Jan 9;273(2):945-9
references.pmid: 9422754
references.citation: Annu Rev Pharmacol Toxicol. 2006;46:411-49
references.pmid: 16402911